U.S. FDA Issues Complete Response Letter for Baricitinib
Go back to U.S. FDA Issues Complete Response Letter for Baricitinib| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 98.22 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.22 | 52 Week High | $118.49 | |||
| Open | $98.22 | 52 Week Low | $55.00 | |||
| Day High | $98.22 | P/E | N/A | |||
| Day Low | $98.22 | EPS | $-0.56 | |||
| Volume | 4,053 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1098.57 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1098.57 | 52 Week High | $88.16 | |||
| Open | $1098.57 | 52 Week Low | $67.88 | |||
| Day High | $1098.57 | P/E | 254.30 | |||
| Day Low | $1098.57 | EPS | $4.32 | |||
| Volume | 2,100 | |||||
